nodes	percent_of_prediction	percent_of_DWPC	metapath
Methylprednisolone—ABCB1—Lopinavir—acquired immunodeficiency syndrome	0.0629	0.0906	CbGbCtD
Methylprednisolone—ABCB1—Amprenavir—acquired immunodeficiency syndrome	0.0569	0.0819	CbGbCtD
Methylprednisolone—ABCB1—Indinavir—acquired immunodeficiency syndrome	0.0491	0.0707	CbGbCtD
Methylprednisolone—ABCB1—Nelfinavir—acquired immunodeficiency syndrome	0.0477	0.0687	CbGbCtD
Methylprednisolone—ABCB1—Ritonavir—acquired immunodeficiency syndrome	0.0431	0.0621	CbGbCtD
Methylprednisolone—ABCB1—Saquinavir—acquired immunodeficiency syndrome	0.0431	0.0621	CbGbCtD
Methylprednisolone—ABCB1—Zidovudine—acquired immunodeficiency syndrome	0.0413	0.0595	CbGbCtD
Methylprednisolone—CYP3A4—Efavirenz—acquired immunodeficiency syndrome	0.0401	0.0577	CbGbCtD
Methylprednisolone—CYP3A4—Lopinavir—acquired immunodeficiency syndrome	0.0377	0.0543	CbGbCtD
Methylprednisolone—CYP3A4—Nevirapine—acquired immunodeficiency syndrome	0.0377	0.0543	CbGbCtD
Methylprednisolone—CYP3A4—Amprenavir—acquired immunodeficiency syndrome	0.0341	0.0491	CbGbCtD
Methylprednisolone—CYP3A4—Delavirdine—acquired immunodeficiency syndrome	0.0341	0.0491	CbGbCtD
Methylprednisolone—ABCB1—Lamivudine—acquired immunodeficiency syndrome	0.032	0.0461	CbGbCtD
Methylprednisolone—CYP3A4—Indinavir—acquired immunodeficiency syndrome	0.0294	0.0424	CbGbCtD
Methylprednisolone—CYP3A4—Nelfinavir—acquired immunodeficiency syndrome	0.0286	0.0411	CbGbCtD
Methylprednisolone—CYP3A4—Saquinavir—acquired immunodeficiency syndrome	0.0258	0.0372	CbGbCtD
Methylprednisolone—CYP3A4—Ritonavir—acquired immunodeficiency syndrome	0.0258	0.0372	CbGbCtD
Methylprednisolone—CYP3A4—Zidovudine—acquired immunodeficiency syndrome	0.0248	0.0357	CbGbCtD
Methylprednisolone—NR3C1—nerve—acquired immunodeficiency syndrome	0.00148	0.122	CbGeAlD
Methylprednisolone—NR3C1—blood plasma—acquired immunodeficiency syndrome	0.00112	0.0923	CbGeAlD
Methylprednisolone—CYP3A4—blood plasma—acquired immunodeficiency syndrome	0.000849	0.0698	CbGeAlD
Methylprednisolone—ABCB1—blood plasma—acquired immunodeficiency syndrome	0.000601	0.0494	CbGeAlD
Methylprednisolone—NR3C1—skin of body—acquired immunodeficiency syndrome	0.00054	0.0444	CbGeAlD
Methylprednisolone—NR3C1—lymphoid tissue—acquired immunodeficiency syndrome	0.000437	0.0359	CbGeAlD
Methylprednisolone—NR3C1—digestive system—acquired immunodeficiency syndrome	0.000432	0.0355	CbGeAlD
Methylprednisolone—NR3C1—blood—acquired immunodeficiency syndrome	0.000411	0.0338	CbGeAlD
Methylprednisolone—NR3C1—bone marrow—acquired immunodeficiency syndrome	0.000398	0.0327	CbGeAlD
Methylprednisolone—NR3C1—spinal cord—acquired immunodeficiency syndrome	0.000396	0.0326	CbGeAlD
Methylprednisolone—NR3C1—vagina—acquired immunodeficiency syndrome	0.000381	0.0313	CbGeAlD
Methylprednisolone—NR3C1—lung—acquired immunodeficiency syndrome	0.000361	0.0296	CbGeAlD
Methylprednisolone—NR3C1—nervous system—acquired immunodeficiency syndrome	0.000334	0.0275	CbGeAlD
Methylprednisolone—ABCB1—retina—acquired immunodeficiency syndrome	0.000329	0.0271	CbGeAlD
Methylprednisolone—CYP3A4—digestive system—acquired immunodeficiency syndrome	0.000327	0.0268	CbGeAlD
Methylprednisolone—NR3C1—central nervous system—acquired immunodeficiency syndrome	0.000321	0.0264	CbGeAlD
Methylprednisolone—CYP3A4—blood—acquired immunodeficiency syndrome	0.000311	0.0256	CbGeAlD
Methylprednisolone—NR3C1—brain—acquired immunodeficiency syndrome	0.000255	0.021	CbGeAlD
Methylprednisolone—CYP3A4—nervous system—acquired immunodeficiency syndrome	0.000253	0.0208	CbGeAlD
Methylprednisolone—NR3C1—lymph node—acquired immunodeficiency syndrome	0.000247	0.0203	CbGeAlD
Methylprednisolone—CYP3A4—central nervous system—acquired immunodeficiency syndrome	0.000243	0.02	CbGeAlD
Methylprednisolone—ABCB1—lymphoid tissue—acquired immunodeficiency syndrome	0.000234	0.0192	CbGeAlD
Methylprednisolone—ABCB1—digestive system—acquired immunodeficiency syndrome	0.000231	0.019	CbGeAlD
Methylprednisolone—ABCB1—blood—acquired immunodeficiency syndrome	0.00022	0.0181	CbGeAlD
Methylprednisolone—ABCB1—bone marrow—acquired immunodeficiency syndrome	0.000213	0.0175	CbGeAlD
Methylprednisolone—ABCB1—spinal cord—acquired immunodeficiency syndrome	0.000212	0.0174	CbGeAlD
Methylprednisolone—ABCB1—vagina—acquired immunodeficiency syndrome	0.000204	0.0168	CbGeAlD
Methylprednisolone—Ill-defined disorder—Ritonavir—acquired immunodeficiency syndrome	0.000204	0.000693	CcSEcCtD
Methylprednisolone—Dyspepsia—Zidovudine—acquired immunodeficiency syndrome	0.000203	0.000691	CcSEcCtD
Methylprednisolone—Hypersensitivity—Nevirapine—acquired immunodeficiency syndrome	0.000202	0.000689	CcSEcCtD
Methylprednisolone—Arthralgia—Delavirdine—acquired immunodeficiency syndrome	0.000202	0.000688	CcSEcCtD
Methylprednisolone—Myalgia—Delavirdine—acquired immunodeficiency syndrome	0.000202	0.000688	CcSEcCtD
Methylprednisolone—Erythema—Lamivudine—acquired immunodeficiency syndrome	0.000202	0.000686	CcSEcCtD
Methylprednisolone—Malnutrition—Lamivudine—acquired immunodeficiency syndrome	0.000202	0.000686	CcSEcCtD
Methylprednisolone—Anxiety—Delavirdine—acquired immunodeficiency syndrome	0.000201	0.000686	CcSEcCtD
Methylprednisolone—Discomfort—Delavirdine—acquired immunodeficiency syndrome	0.0002	0.00068	CcSEcCtD
Methylprednisolone—Shock—Efavirenz—acquired immunodeficiency syndrome	0.000199	0.000678	CcSEcCtD
Methylprednisolone—Nausea—Amprenavir—acquired immunodeficiency syndrome	0.000199	0.000677	CcSEcCtD
Methylprednisolone—Fatigue—Zidovudine—acquired immunodeficiency syndrome	0.000199	0.000676	CcSEcCtD
Methylprednisolone—Nervous system disorder—Efavirenz—acquired immunodeficiency syndrome	0.000199	0.000676	CcSEcCtD
Methylprednisolone—Malaise—Ritonavir—acquired immunodeficiency syndrome	0.000198	0.000674	CcSEcCtD
Methylprednisolone—Tachycardia—Efavirenz—acquired immunodeficiency syndrome	0.000198	0.000673	CcSEcCtD
Methylprednisolone—Vertigo—Ritonavir—acquired immunodeficiency syndrome	0.000197	0.000672	CcSEcCtD
Methylprednisolone—Asthenia—Nevirapine—acquired immunodeficiency syndrome	0.000197	0.000671	CcSEcCtD
Methylprednisolone—Syncope—Ritonavir—acquired immunodeficiency syndrome	0.000197	0.00067	CcSEcCtD
Methylprednisolone—Skin disorder—Efavirenz—acquired immunodeficiency syndrome	0.000197	0.00067	CcSEcCtD
Methylprednisolone—Ill-defined disorder—Saquinavir—acquired immunodeficiency syndrome	0.000196	0.000667	CcSEcCtD
Methylprednisolone—Hypersensitivity—Nelfinavir—acquired immunodeficiency syndrome	0.000196	0.000667	CcSEcCtD
Methylprednisolone—Hyperhidrosis—Efavirenz—acquired immunodeficiency syndrome	0.000196	0.000666	CcSEcCtD
Methylprednisolone—Confusional state—Delavirdine—acquired immunodeficiency syndrome	0.000195	0.000665	CcSEcCtD
Methylprednisolone—Hypersensitivity—Stavudine—acquired immunodeficiency syndrome	0.000195	0.000665	CcSEcCtD
Methylprednisolone—Musculoskeletal discomfort—Indinavir—acquired immunodeficiency syndrome	0.000195	0.000665	CcSEcCtD
Methylprednisolone—Pruritus—Nevirapine—acquired immunodeficiency syndrome	0.000194	0.000661	CcSEcCtD
Methylprednisolone—Vomiting—Didanosine—acquired immunodeficiency syndrome	0.000194	0.000661	CcSEcCtD
Methylprednisolone—Insomnia—Indinavir—acquired immunodeficiency syndrome	0.000194	0.00066	CcSEcCtD
Methylprednisolone—ABCB1—lung—acquired immunodeficiency syndrome	0.000193	0.0159	CbGeAlD
Methylprednisolone—Loss of consciousness—Ritonavir—acquired immunodeficiency syndrome	0.000193	0.000657	CcSEcCtD
Methylprednisolone—Rash—Didanosine—acquired immunodeficiency syndrome	0.000193	0.000656	CcSEcCtD
Methylprednisolone—Infection—Delavirdine—acquired immunodeficiency syndrome	0.000193	0.000655	CcSEcCtD
Methylprednisolone—Paraesthesia—Indinavir—acquired immunodeficiency syndrome	0.000193	0.000655	CcSEcCtD
Methylprednisolone—Hypersensitivity—Abacavir—acquired immunodeficiency syndrome	0.000192	0.000655	CcSEcCtD
Methylprednisolone—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.000192	0.000655	CcSEcCtD
Methylprednisolone—Headache—Didanosine—acquired immunodeficiency syndrome	0.000191	0.000651	CcSEcCtD
Methylprednisolone—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	0.000191	0.00065	CcSEcCtD
Methylprednisolone—Shock—Delavirdine—acquired immunodeficiency syndrome	0.000191	0.000649	CcSEcCtD
Methylprednisolone—Malaise—Saquinavir—acquired immunodeficiency syndrome	0.000191	0.000649	CcSEcCtD
Methylprednisolone—Asthenia—Stavudine—acquired immunodeficiency syndrome	0.00019	0.000648	CcSEcCtD
Methylprednisolone—Convulsion—Ritonavir—acquired immunodeficiency syndrome	0.00019	0.000648	CcSEcCtD
Methylprednisolone—Feeling abnormal—Zidovudine—acquired immunodeficiency syndrome	0.00019	0.000647	CcSEcCtD
Methylprednisolone—Vertigo—Saquinavir—acquired immunodeficiency syndrome	0.00019	0.000646	CcSEcCtD
Methylprednisolone—Hypertension—Ritonavir—acquired immunodeficiency syndrome	0.00019	0.000645	CcSEcCtD
Methylprednisolone—Syncope—Saquinavir—acquired immunodeficiency syndrome	0.00019	0.000645	CcSEcCtD
Methylprednisolone—Tachycardia—Delavirdine—acquired immunodeficiency syndrome	0.000189	0.000644	CcSEcCtD
Methylprednisolone—Dyspepsia—Indinavir—acquired immunodeficiency syndrome	0.000189	0.000642	CcSEcCtD
Methylprednisolone—Gastrointestinal pain—Zidovudine—acquired immunodeficiency syndrome	0.000189	0.000642	CcSEcCtD
Methylprednisolone—Skin disorder—Delavirdine—acquired immunodeficiency syndrome	0.000188	0.000641	CcSEcCtD
Methylprednisolone—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	0.000188	0.000641	CcSEcCtD
Methylprednisolone—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.000188	0.00064	CcSEcCtD
Methylprednisolone—Pruritus—Stavudine—acquired immunodeficiency syndrome	0.000188	0.000639	CcSEcCtD
Methylprednisolone—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.000187	0.000638	CcSEcCtD
Methylprednisolone—Hyperhidrosis—Delavirdine—acquired immunodeficiency syndrome	0.000187	0.000638	CcSEcCtD
Methylprednisolone—Ill-defined disorder—Lamivudine—acquired immunodeficiency syndrome	0.000187	0.000637	CcSEcCtD
Methylprednisolone—Arthralgia—Ritonavir—acquired immunodeficiency syndrome	0.000187	0.000636	CcSEcCtD
Methylprednisolone—Myalgia—Ritonavir—acquired immunodeficiency syndrome	0.000187	0.000636	CcSEcCtD
Methylprednisolone—Anxiety—Ritonavir—acquired immunodeficiency syndrome	0.000186	0.000634	CcSEcCtD
Methylprednisolone—Loss of consciousness—Saquinavir—acquired immunodeficiency syndrome	0.000186	0.000632	CcSEcCtD
Methylprednisolone—Unspecified disorder of skin and subcutaneous tissue—Ritonavir—acquired immunodeficiency syndrome	0.000186	0.000632	CcSEcCtD
Methylprednisolone—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.000185	0.000629	CcSEcCtD
Methylprednisolone—Fatigue—Indinavir—acquired immunodeficiency syndrome	0.000185	0.000629	CcSEcCtD
Methylprednisolone—Discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000185	0.000629	CcSEcCtD
Methylprednisolone—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	0.000185	0.000628	CcSEcCtD
Methylprednisolone—Angioedema—Lamivudine—acquired immunodeficiency syndrome	0.000184	0.000627	CcSEcCtD
Methylprednisolone—Insomnia—Efavirenz—acquired immunodeficiency syndrome	0.000183	0.000624	CcSEcCtD
Methylprednisolone—Urticaria—Zidovudine—acquired immunodeficiency syndrome	0.000183	0.000623	CcSEcCtD
Methylprednisolone—Convulsion—Saquinavir—acquired immunodeficiency syndrome	0.000183	0.000623	CcSEcCtD
Methylprednisolone—Hypertension—Saquinavir—acquired immunodeficiency syndrome	0.000182	0.000621	CcSEcCtD
Methylprednisolone—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	0.000182	0.00062	CcSEcCtD
Methylprednisolone—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.000182	0.00062	CcSEcCtD
Methylprednisolone—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	0.000182	0.000619	CcSEcCtD
Methylprednisolone—Malaise—Lamivudine—acquired immunodeficiency syndrome	0.000182	0.000619	CcSEcCtD
Methylprednisolone—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.000181	0.000618	CcSEcCtD
Methylprednisolone—Nausea—Didanosine—acquired immunodeficiency syndrome	0.000181	0.000618	CcSEcCtD
Methylprednisolone—Vertigo—Lamivudine—acquired immunodeficiency syndrome	0.000181	0.000617	CcSEcCtD
Methylprednisolone—Hypotension—Delavirdine—acquired immunodeficiency syndrome	0.000181	0.000616	CcSEcCtD
Methylprednisolone—Syncope—Lamivudine—acquired immunodeficiency syndrome	0.000181	0.000615	CcSEcCtD
Methylprednisolone—Confusional state—Ritonavir—acquired immunodeficiency syndrome	0.000181	0.000615	CcSEcCtD
Methylprednisolone—Arthralgia—Saquinavir—acquired immunodeficiency syndrome	0.00018	0.000612	CcSEcCtD
Methylprednisolone—Myalgia—Saquinavir—acquired immunodeficiency syndrome	0.00018	0.000612	CcSEcCtD
Methylprednisolone—Anxiety—Saquinavir—acquired immunodeficiency syndrome	0.000179	0.00061	CcSEcCtD
Methylprednisolone—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.000179	0.000608	CcSEcCtD
Methylprednisolone—ABCB1—nervous system—acquired immunodeficiency syndrome	0.000179	0.0147	CbGeAlD
Methylprednisolone—Unspecified disorder of skin and subcutaneous tissue—Saquinavir—acquired immunodeficiency syndrome	0.000179	0.000608	CcSEcCtD
Methylprednisolone—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	0.000178	0.000607	CcSEcCtD
Methylprednisolone—Discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000178	0.000605	CcSEcCtD
Methylprednisolone—Loss of consciousness—Lamivudine—acquired immunodeficiency syndrome	0.000177	0.000603	CcSEcCtD
Methylprednisolone—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	0.000177	0.000601	CcSEcCtD
Methylprednisolone—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	0.000177	0.000601	CcSEcCtD
Methylprednisolone—Shock—Ritonavir—acquired immunodeficiency syndrome	0.000176	0.0006	CcSEcCtD
Methylprednisolone—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.000176	0.000599	CcSEcCtD
Methylprednisolone—Nervous system disorder—Ritonavir—acquired immunodeficiency syndrome	0.000176	0.000598	CcSEcCtD
Methylprednisolone—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.000175	0.000597	CcSEcCtD
Methylprednisolone—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	0.000175	0.000597	CcSEcCtD
Methylprednisolone—Insomnia—Delavirdine—acquired immunodeficiency syndrome	0.000175	0.000597	CcSEcCtD
Methylprednisolone—Tachycardia—Ritonavir—acquired immunodeficiency syndrome	0.000175	0.000595	CcSEcCtD
Methylprednisolone—Convulsion—Lamivudine—acquired immunodeficiency syndrome	0.000175	0.000595	CcSEcCtD
Methylprednisolone—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.000175	0.000594	CcSEcCtD
Methylprednisolone—Fatigue—Efavirenz—acquired immunodeficiency syndrome	0.000175	0.000594	CcSEcCtD
Methylprednisolone—Skin disorder—Ritonavir—acquired immunodeficiency syndrome	0.000174	0.000593	CcSEcCtD
Methylprednisolone—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	0.000174	0.000592	CcSEcCtD
Methylprednisolone—Confusional state—Saquinavir—acquired immunodeficiency syndrome	0.000174	0.000592	CcSEcCtD
Methylprednisolone—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	0.000173	0.00059	CcSEcCtD
Methylprednisolone—Rash—Nevirapine—acquired immunodeficiency syndrome	0.000173	0.000589	CcSEcCtD
Methylprednisolone—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.000173	0.000589	CcSEcCtD
Methylprednisolone—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.000173	0.000588	CcSEcCtD
Methylprednisolone—ABCB1—central nervous system—acquired immunodeficiency syndrome	0.000172	0.0142	CbGeAlD
Methylprednisolone—Headache—Nevirapine—acquired immunodeficiency syndrome	0.000172	0.000586	CcSEcCtD
Methylprednisolone—Myalgia—Lamivudine—acquired immunodeficiency syndrome	0.000172	0.000584	CcSEcCtD
Methylprednisolone—Arthralgia—Lamivudine—acquired immunodeficiency syndrome	0.000172	0.000584	CcSEcCtD
Methylprednisolone—Infection—Saquinavir—acquired immunodeficiency syndrome	0.000171	0.000583	CcSEcCtD
Methylprednisolone—Anxiety—Lamivudine—acquired immunodeficiency syndrome	0.000171	0.000582	CcSEcCtD
Methylprednisolone—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	0.000171	0.000581	CcSEcCtD
Methylprednisolone—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—acquired immunodeficiency syndrome	0.00017	0.00058	CcSEcCtD
Methylprednisolone—Urticaria—Indinavir—acquired immunodeficiency syndrome	0.00017	0.00058	CcSEcCtD
Methylprednisolone—Shock—Saquinavir—acquired immunodeficiency syndrome	0.00017	0.000578	CcSEcCtD
Methylprednisolone—Discomfort—Lamivudine—acquired immunodeficiency syndrome	0.00017	0.000577	CcSEcCtD
Methylprednisolone—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	0.000169	0.000577	CcSEcCtD
Methylprednisolone—Nervous system disorder—Saquinavir—acquired immunodeficiency syndrome	0.000169	0.000576	CcSEcCtD
Methylprednisolone—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.000169	0.000576	CcSEcCtD
Methylprednisolone—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.000169	0.000574	CcSEcCtD
Methylprednisolone—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.000168	0.000571	CcSEcCtD
Methylprednisolone—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.000168	0.00057	CcSEcCtD
Methylprednisolone—Skin disorder—Saquinavir—acquired immunodeficiency syndrome	0.000168	0.00057	CcSEcCtD
Methylprednisolone—Hypotension—Ritonavir—acquired immunodeficiency syndrome	0.000167	0.00057	CcSEcCtD
Methylprednisolone—Rash—Stavudine—acquired immunodeficiency syndrome	0.000167	0.000569	CcSEcCtD
Methylprednisolone—Fatigue—Delavirdine—acquired immunodeficiency syndrome	0.000167	0.000569	CcSEcCtD
Methylprednisolone—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.000167	0.000569	CcSEcCtD
Methylprednisolone—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	0.000167	0.000568	CcSEcCtD
Methylprednisolone—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	0.000167	0.000568	CcSEcCtD
Methylprednisolone—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.000167	0.000567	CcSEcCtD
Methylprednisolone—Headache—Stavudine—acquired immunodeficiency syndrome	0.000166	0.000566	CcSEcCtD
Methylprednisolone—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.000166	0.000565	CcSEcCtD
Methylprednisolone—Confusional state—Lamivudine—acquired immunodeficiency syndrome	0.000166	0.000565	CcSEcCtD
Methylprednisolone—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	0.000166	0.000564	CcSEcCtD
Methylprednisolone—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.000165	0.000563	CcSEcCtD
Methylprednisolone—Rash—Abacavir—acquired immunodeficiency syndrome	0.000165	0.000561	CcSEcCtD
Methylprednisolone—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.000165	0.00056	CcSEcCtD
Methylprednisolone—Anaphylactic shock—Lamivudine—acquired immunodeficiency syndrome	0.000165	0.00056	CcSEcCtD
Methylprednisolone—Headache—Abacavir—acquired immunodeficiency syndrome	0.000164	0.000557	CcSEcCtD
Methylprednisolone—Infection—Lamivudine—acquired immunodeficiency syndrome	0.000163	0.000556	CcSEcCtD
Methylprednisolone—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000163	0.000556	CcSEcCtD
Methylprednisolone—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.000163	0.000555	CcSEcCtD
Methylprednisolone—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.000163	0.000555	CcSEcCtD
Methylprednisolone—Insomnia—Ritonavir—acquired immunodeficiency syndrome	0.000162	0.000552	CcSEcCtD
Methylprednisolone—Shock—Lamivudine—acquired immunodeficiency syndrome	0.000162	0.000551	CcSEcCtD
Methylprednisolone—Nervous system disorder—Lamivudine—acquired immunodeficiency syndrome	0.000161	0.000549	CcSEcCtD
Methylprednisolone—Hypotension—Saquinavir—acquired immunodeficiency syndrome	0.000161	0.000549	CcSEcCtD
Methylprednisolone—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	0.000161	0.000548	CcSEcCtD
Methylprednisolone—Urticaria—Efavirenz—acquired immunodeficiency syndrome	0.000161	0.000548	CcSEcCtD
Methylprednisolone—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	0.00016	0.000545	CcSEcCtD
Methylprednisolone—Skin disorder—Lamivudine—acquired immunodeficiency syndrome	0.00016	0.000544	CcSEcCtD
Methylprednisolone—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	0.00016	0.000544	CcSEcCtD
Methylprednisolone—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	0.000159	0.000541	CcSEcCtD
Methylprednisolone—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	0.000158	0.000539	CcSEcCtD
Methylprednisolone—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.000158	0.000538	CcSEcCtD
Methylprednisolone—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	0.000158	0.000538	CcSEcCtD
Methylprednisolone—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	0.000158	0.000537	CcSEcCtD
Methylprednisolone—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.000158	0.000537	CcSEcCtD
Methylprednisolone—Nausea—Stavudine—acquired immunodeficiency syndrome	0.000158	0.000536	CcSEcCtD
Methylprednisolone—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000157	0.000535	CcSEcCtD
Methylprednisolone—Insomnia—Saquinavir—acquired immunodeficiency syndrome	0.000156	0.000531	CcSEcCtD
Methylprednisolone—Nausea—Abacavir—acquired immunodeficiency syndrome	0.000155	0.000528	CcSEcCtD
Methylprednisolone—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	0.000155	0.000527	CcSEcCtD
Methylprednisolone—Fatigue—Ritonavir—acquired immunodeficiency syndrome	0.000155	0.000526	CcSEcCtD
Methylprednisolone—Urticaria—Delavirdine—acquired immunodeficiency syndrome	0.000154	0.000524	CcSEcCtD
Methylprednisolone—Asthenia—Indinavir—acquired immunodeficiency syndrome	0.000154	0.000524	CcSEcCtD
Methylprednisolone—Hypotension—Lamivudine—acquired immunodeficiency syndrome	0.000154	0.000523	CcSEcCtD
Methylprednisolone—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	0.000153	0.000521	CcSEcCtD
Methylprednisolone—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.000152	0.000519	CcSEcCtD
Methylprednisolone—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	0.000152	0.000517	CcSEcCtD
Methylprednisolone—Pruritus—Indinavir—acquired immunodeficiency syndrome	0.000152	0.000516	CcSEcCtD
Methylprednisolone—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	0.00015	0.00051	CcSEcCtD
Methylprednisolone—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	0.000149	0.000508	CcSEcCtD
Methylprednisolone—Insomnia—Lamivudine—acquired immunodeficiency syndrome	0.000149	0.000507	CcSEcCtD
Methylprednisolone—Fatigue—Saquinavir—acquired immunodeficiency syndrome	0.000149	0.000506	CcSEcCtD
Methylprednisolone—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	0.000148	0.000503	CcSEcCtD
Methylprednisolone—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	0.000148	0.000503	CcSEcCtD
Methylprednisolone—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.000147	0.000499	CcSEcCtD
Methylprednisolone—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.000147	0.000499	CcSEcCtD
Methylprednisolone—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	0.000147	0.000499	CcSEcCtD
Methylprednisolone—Rash—Zidovudine—acquired immunodeficiency syndrome	0.000145	0.000495	CcSEcCtD
Methylprednisolone—Asthenia—Efavirenz—acquired immunodeficiency syndrome	0.000145	0.000495	CcSEcCtD
Methylprednisolone—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.000145	0.000494	CcSEcCtD
Methylprednisolone—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	0.000145	0.000493	CcSEcCtD
Methylprednisolone—Headache—Zidovudine—acquired immunodeficiency syndrome	0.000144	0.000492	CcSEcCtD
Methylprednisolone—Pruritus—Efavirenz—acquired immunodeficiency syndrome	0.000143	0.000488	CcSEcCtD
Methylprednisolone—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	0.000143	0.000486	CcSEcCtD
Methylprednisolone—Urticaria—Ritonavir—acquired immunodeficiency syndrome	0.000142	0.000485	CcSEcCtD
Methylprednisolone—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	0.000142	0.000484	CcSEcCtD
Methylprednisolone—Fatigue—Lamivudine—acquired immunodeficiency syndrome	0.000142	0.000483	CcSEcCtD
Methylprednisolone—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.000142	0.000483	CcSEcCtD
Methylprednisolone—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	0.000142	0.000482	CcSEcCtD
Methylprednisolone—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	0.000141	0.00048	CcSEcCtD
Methylprednisolone—Asthenia—Delavirdine—acquired immunodeficiency syndrome	0.000139	0.000473	CcSEcCtD
Methylprednisolone—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	0.000139	0.000472	CcSEcCtD
Methylprednisolone—Pruritus—Delavirdine—acquired immunodeficiency syndrome	0.000137	0.000467	CcSEcCtD
Methylprednisolone—Urticaria—Saquinavir—acquired immunodeficiency syndrome	0.000137	0.000466	CcSEcCtD
Methylprednisolone—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.000137	0.000466	CcSEcCtD
Methylprednisolone—ABCB1—brain—acquired immunodeficiency syndrome	0.000137	0.0112	CbGeAlD
Methylprednisolone—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	0.000136	0.000464	CcSEcCtD
Methylprednisolone—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.000136	0.000464	CcSEcCtD
Methylprednisolone—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	0.000136	0.000462	CcSEcCtD
Methylprednisolone—Rash—Indinavir—acquired immunodeficiency syndrome	0.000135	0.00046	CcSEcCtD
Methylprednisolone—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.000135	0.00046	CcSEcCtD
Methylprednisolone—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	0.000135	0.000458	CcSEcCtD
Methylprednisolone—Headache—Indinavir—acquired immunodeficiency syndrome	0.000134	0.000457	CcSEcCtD
Methylprednisolone—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.000134	0.000456	CcSEcCtD
Methylprednisolone—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	0.000133	0.000451	CcSEcCtD
Methylprednisolone—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	0.000132	0.000449	CcSEcCtD
Methylprednisolone—ABCB1—lymph node—acquired immunodeficiency syndrome	0.000132	0.0109	CbGeAlD
Methylprednisolone—Urticaria—Lamivudine—acquired immunodeficiency syndrome	0.000131	0.000445	CcSEcCtD
Methylprednisolone—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	0.00013	0.000443	CcSEcCtD
Methylprednisolone—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.000129	0.000438	CcSEcCtD
Methylprednisolone—Asthenia—Ritonavir—acquired immunodeficiency syndrome	0.000129	0.000438	CcSEcCtD
Methylprednisolone—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.000128	0.000436	CcSEcCtD
Methylprednisolone—Rash—Efavirenz—acquired immunodeficiency syndrome	0.000128	0.000435	CcSEcCtD
Methylprednisolone—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.000128	0.000434	CcSEcCtD
Methylprednisolone—Nausea—Indinavir—acquired immunodeficiency syndrome	0.000127	0.000433	CcSEcCtD
Methylprednisolone—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	0.000127	0.000433	CcSEcCtD
Methylprednisolone—Headache—Efavirenz—acquired immunodeficiency syndrome	0.000127	0.000432	CcSEcCtD
Methylprednisolone—Pruritus—Ritonavir—acquired immunodeficiency syndrome	0.000127	0.000432	CcSEcCtD
Methylprednisolone—Asthenia—Saquinavir—acquired immunodeficiency syndrome	0.000124	0.000421	CcSEcCtD
Methylprednisolone—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.000123	0.000419	CcSEcCtD
Methylprednisolone—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	0.000123	0.000417	CcSEcCtD
Methylprednisolone—Rash—Delavirdine—acquired immunodeficiency syndrome	0.000122	0.000416	CcSEcCtD
Methylprednisolone—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.000122	0.000416	CcSEcCtD
Methylprednisolone—Pruritus—Saquinavir—acquired immunodeficiency syndrome	0.000122	0.000415	CcSEcCtD
Methylprednisolone—Headache—Delavirdine—acquired immunodeficiency syndrome	0.000121	0.000413	CcSEcCtD
Methylprednisolone—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	0.000121	0.000413	CcSEcCtD
Methylprednisolone—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.00012	0.00041	CcSEcCtD
Methylprednisolone—Dizziness—Ritonavir—acquired immunodeficiency syndrome	0.000119	0.000403	CcSEcCtD
Methylprednisolone—Asthenia—Lamivudine—acquired immunodeficiency syndrome	0.000118	0.000402	CcSEcCtD
Methylprednisolone—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	0.000118	0.000402	CcSEcCtD
Methylprednisolone—Pruritus—Lamivudine—acquired immunodeficiency syndrome	0.000116	0.000396	CcSEcCtD
Methylprednisolone—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.000115	0.000392	CcSEcCtD
Methylprednisolone—Dizziness—Saquinavir—acquired immunodeficiency syndrome	0.000114	0.000388	CcSEcCtD
Methylprednisolone—Vomiting—Ritonavir—acquired immunodeficiency syndrome	0.000114	0.000388	CcSEcCtD
Methylprednisolone—Rash—Ritonavir—acquired immunodeficiency syndrome	0.000113	0.000385	CcSEcCtD
Methylprednisolone—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	0.000113	0.000384	CcSEcCtD
Methylprednisolone—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	0.000113	0.000383	CcSEcCtD
Methylprednisolone—Headache—Ritonavir—acquired immunodeficiency syndrome	0.000112	0.000382	CcSEcCtD
Methylprednisolone—Vomiting—Saquinavir—acquired immunodeficiency syndrome	0.00011	0.000373	CcSEcCtD
Methylprednisolone—Dizziness—Lamivudine—acquired immunodeficiency syndrome	0.000109	0.00037	CcSEcCtD
Methylprednisolone—Rash—Saquinavir—acquired immunodeficiency syndrome	0.000109	0.00037	CcSEcCtD
Methylprednisolone—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	0.000109	0.00037	CcSEcCtD
Methylprednisolone—Headache—Saquinavir—acquired immunodeficiency syndrome	0.000108	0.000368	CcSEcCtD
Methylprednisolone—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.000106	0.000362	CcSEcCtD
Methylprednisolone—Vomiting—Lamivudine—acquired immunodeficiency syndrome	0.000105	0.000356	CcSEcCtD
Methylprednisolone—Rash—Lamivudine—acquired immunodeficiency syndrome	0.000104	0.000353	CcSEcCtD
Methylprednisolone—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	0.000104	0.000353	CcSEcCtD
Methylprednisolone—Headache—Lamivudine—acquired immunodeficiency syndrome	0.000103	0.000351	CcSEcCtD
Methylprednisolone—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.000102	0.000349	CcSEcCtD
Methylprednisolone—Nausea—Lamivudine—acquired immunodeficiency syndrome	9.77e-05	0.000333	CcSEcCtD
